These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19151639)

  • 1. The price of success: cost-effectiveness of molecularly targeted agents.
    Sleijfer S; Verweij J
    Clin Pharmacol Ther; 2009 Feb; 85(2):136-8. PubMed ID: 19151639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature.
    Becker R; Dembek C; White LA; Garrison LP
    Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):775-93. PubMed ID: 23252359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent development of targeted drug delivery system].
    Zhou PJ; Deng SQ; Gong QF
    Yao Xue Xue Bao; 2010 Mar; 45(3):300-6. PubMed ID: 21351504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on ready-to-use intravenous delivery systems.
    Maliekal J; Bertch KE; Witte KW
    Hosp Pharm; 1993 Oct; 28(10):970-1, 975-7. PubMed ID: 10171701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost effective approach to treatment of infection: "switch therapy".
    Burnakis TG
    Hosp Pharm; 1992 Apr; 27(4):353-4, 360. PubMed ID: 10117773
    [No Abstract]   [Full Text] [Related]  

  • 7. The emerging market dynamics of targeted therapeutics.
    Calfee JE; Dupré E
    Health Aff (Millwood); 2006; 25(5):1302-8. PubMed ID: 16966726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Important to keep the principle of value-based pricing of drugs].
    Persson U; Levin LA; Pettersson B
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2862-4. PubMed ID: 19967967
    [No Abstract]   [Full Text] [Related]  

  • 9. [New drugs in Spain -- when are they to be considered cost-effective alternatives and profitable investments for the National Health System? ].
    Soto Alvarez J
    Farm Hosp; 2004; 28(4):299-304. PubMed ID: 15369442
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost of preventive drugs. Dare to tell?
    Trewby PN
    BMJ; 2011 May; 342():d3198. PubMed ID: 21610062
    [No Abstract]   [Full Text] [Related]  

  • 11. Loading doses for costly cancer biologicals: sound pharmacology or unnecessary extravagance?
    Epstein RJ; Cheung BM
    Eur J Cancer; 2008 Jul; 44(11):1488-92. PubMed ID: 18194858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Follow up studies as a condition for drug subsidizing].
    Kieler H; Ekbom A; Fored M; Montgomery SM; Wettermark B
    Lakartidningen; 2009 May 13-19; 106(20):1406-7. PubMed ID: 19585842
    [No Abstract]   [Full Text] [Related]  

  • 13. Seven therapeutic categories account for most drug cost increases.
    Manag Care; 2011 Dec; 20(12):69. PubMed ID: 22259880
    [No Abstract]   [Full Text] [Related]  

  • 14. At what price?
    Danzon PM
    Nature; 2007 Sep; 449(7159):176-9. PubMed ID: 17851515
    [No Abstract]   [Full Text] [Related]  

  • 15. The true cost of pharmacological disease prevention.
    Järvinen TL; Sievänen H; Kannus P; Jokihaara J; Khan KM
    BMJ; 2011 Apr; 342():d2175. PubMed ID: 21505222
    [No Abstract]   [Full Text] [Related]  

  • 16. Payers struggle to ensure high level of adherence to costly specialty drugs.
    Sipkoff M
    Manag Care; 2008 Jul; 17(7):24-6, 29, 31. PubMed ID: 18757021
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug delivery systems improve pharmaceutical profile and facilitate medication adherence.
    Wertheimer AI; Santella TM; Finestone AJ; Levy RA
    Adv Ther; 2005; 22(6):559-77. PubMed ID: 16510373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery.
    Sharifi E; Porco TC; Naseri A
    Ophthalmology; 2009 Oct; 116(10):1887-96.e1. PubMed ID: 19560825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insurers and 'targeted biologics' for cancer: a conversation with Lee N. Newcomer. Interview by Barbara J. Culliton.
    Newcomer LN
    Health Aff (Millwood); 2008; 27(1):w41-51. PubMed ID: 18042562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications for site-directed molecular imaging agents coupled with drug delivery potential.
    Wang H; Chen X
    Expert Opin Drug Deliv; 2009 Jul; 6(7):745-68. PubMed ID: 19552614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.